Therapies being developed for tissue fibrosis that target signaling pathways regulating TGFβ-associated transcription factors might be effective in preventing the decline in adipocyte-specific functions during obesity. Here, TGFB1 is linked to obesity due to melanocortin 4 receptor deficiency.